Beyond its role in EndMT, GDF15 promotes AKT phosphorylation in a TGFBR2-dependent manner, hence increasing the resistance of esophageal squamous cell carcinoma cells to low-dose cisplatin [50]. The gene discussed is TGFBR2; the disease is esophageal squamous cell carcinoma.